Health
New targeted therapy blocks metabolism in brain cancer cells with genetic vulnerability – Medical Xpress
Researchers at The University of Texas MD Anderson Cancer Center have developed a novel targeted therapy, called POMHEX, which blocks critical metabolic pathways…
Researchers at The University of Texas MD Anderson Cancer Center have developed a novel targeted therapy, called POMHEX, which blocks critical metabolic pathways in cancer cells with specific genetic defects. Preclinical studies found the small-molecule enolase inhibitor to be effective in killing brain cancer cells that were missing ENO1, one of two genes encoding the enolase enzyme.
The study results, published today in Nature Metabolism, provide proof of principle for a treatment strategy known…
-
Business18 hours agoMacquarie tips 14% upside for this ASX tech stock
-
Noosa News14 hours agoWilliam Robinson dies aged 89
-
Noosa News15 hours agoAFL live updates: Gold Coast vs Essendon – blog, scores and stats
-
Noosa News15 hours agoTwo-time Archibald Prize-winning painter William Robinson has died, aged 89